Immunoblotting experiments showed significantly lower nuclear levels of TG2 and phospho-p65 proteins, along with significantly higher levels of IκB protein, in APL cells after 5 days of cotreatment with ATRA and 25(OH)D3 (Fig. 5G–H). This evidence concerns the gene TGM2 and acute promyelocytic leukemia.